The Swiss Times - Swiss News in English

Lonza to produce Vaxcyte vaccine candidates in Visp

  • By The Swiss Times
  • 16 October 2023

Lonza has won another customer for its biopharmaceutical production complex “Ibex” in Visp. The pharmaceutical supplier is cooperating with the US company Vaxcyte in the development of vaccine candidates against pneumococcal diseases.

Lonza to produce Vaxcyte vaccine candidates in Visp
(Source: X.com)

Lonza said on Monday the agreement includes potential global commercialisation of candidates VAX-24 and VAX-31. Under the terms of the agreement, Lonza will provide Vaxcyte with a “customised” manufacturing suite.

Construction of the facility is nearly complete, it said, and installation of the devices will begin in 2024. Upon reaching peak capacity, Lonza will create up to 300 new jobs, it added. Financial details of the agreement were not disclosed.

Lonza has thus won its next contract in Visp after the loss of the Corona vaccine production for the US company Moderna. Already at the beginning of October, the cooperation with an existing customer in the field of antibody-drug conjugates (ADC) was extended. Thanks to this order, around 180 jobs will be created.

©Keystone/SDA

Most Read

Sunday, April 7 – Round Up

7 April 2024
Sunday, April 7 – Round Up
Switzerland may fund French nuclear projects as it grapples with internal issues in the news this Sunday morning.

Swiss Employers Association: Increase Retirement Ages

8 April 2024
Swiss Employers Association: Increase Retirement Ages
Following the rejection of a pension initiative, the Swiss Employers' Association (SAV) recommends a gradual raise in retirement age to 66.

Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec

12 April 2024
Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec
Diehl Defence collaborates with Skysec Defence under a new agreement to enhance drone defense capabilities for military use.

Zurich VC Lakestar Secures $600 Million In New Funds

12 April 2024
Zurich VC Lakestar Secures $600 Million In New Funds
Lakestar successfully closes two new funds, accumulating $600 million, to advance Europe's digital sovereignty.

Stay in Touch!

Noteworthy

Thai Central Group to Allegedly Takeover KaDeWe
Thai Central Group to Allegedly Takeover KaDeWe
12 April 2024
Leonteq and Raiffeisen Extend Partnership
Leonteq and Raiffeisen Extend Partnership
12 April 2024